Worawon Chailimpamontree
Overview
Explore the profile of Worawon Chailimpamontree including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trakarnvanich T, Chailimpamontree W, Kantachuvesiri S, Anutrakulchai S, Manomaipiboon B, Ngamvitchukorn T, et al.
J Prim Care Community Health
. 2024 Nov;
15:21501319241297766.
PMID: 39526855
Introduction: A causal relationship exists between salt intake and hypertension, stroke, and kidney disease. However, whether or not reduced salt intake slows progression of renal diseases has been intensely debated....
2.
Chittinandana P, Gojaseni P, Chuasuwan A, Singprasert R, Chailimpamontree W, Chittinandana A
J Nephrol
. 2024 Jun;
37(8):2275-2283.
PMID: 38940998
Background: Chronic kidney disease (CKD) is a public health problem worldwide. Multidisciplinary care has been recommended in clinical practice to delay disease progression and minimize complications. However, the effectiveness of...
3.
Kantachuvesiri S, Chailimpamontree W, Kunjang A, Chotipokasap N, Pomsanthia N, Raksaphet N, et al.
Lancet Reg Health Southeast Asia
. 2024 Apr;
26:100406.
PMID: 38617086
No abstract available.
4.
Chailimpamontree W, Kantachuvesiri S, Aekplakorn W, Lappichetpaiboon R, Thokanit N, Vathesatogkit P, et al.
J Clin Hypertens (Greenwich)
. 2021 Jan;
23(4):744-754.
PMID: 33420751
Thailand has committed to reducing population sodium intake by 30% by 2025. However, reliable nationally representative data are unavailable for monitoring progress toward the goal. We estimated dietary sodium consumption...
5.
Perkovic V, Craig J, Chailimpamontree W, Fox C, Garcia-Garcia G, Gharbi M, et al.
Kidney Int Suppl (2011)
. 2019 Jan;
7(2):138-144.
PMID: 30675428
High-quality clinical trials are the cornerstone of evidence-based prevention and treatment of a disease, but nephrology has a strikingly weak base of such trials. Building the evidence base to improve...
6.
Jardine M, Kasiske B, Adu D, Alrukhaimi M, Ashuntantang G, Basnet S, et al.
Kidney Int Suppl (2011)
. 2019 Jan;
7(2):114-121.
PMID: 30675425
There are major gaps between our growing knowledge of effective treatments for chronic kidney disease (CKD), and the delivery of evidence-based therapies to populations around the world. Although there remains...
7.
Gojaseni P, Phaopha A, Chailimpamontree W, Pajareya T, Chittinandana A
Vasc Health Risk Manag
. 2010 May;
6:157-65.
PMID: 20448800
Purpose: To assess the prevalence and risk factors of microalbuminuria in nondiabetic hypertensive patients in Thailand. Patients And Methods: A cross-sectional study was performed during January to December 2007 at...
8.
Barraclough K, Landsberg D, Shapiro R, Gill J, Li G, Balshaw R, et al.
Transplantation
. 2009 Mar;
87(5):672-80.
PMID: 19295311
Background: This longitudinal, sequential, matched closed-cohort design pharmacoepidemiological analysis examined the influence of maintenance steroid therapy in 380 first graft recipients after renal transplantation under conditions of normal clinical practice....
9.
Chailimpamontree W, Dmitrienko S, Li G, Balshaw R, Magil A, Shapiro R, et al.
J Am Soc Nephrol
. 2009 Feb;
20(4):843-51.
PMID: 19193778
Glomerulonephritis (GN) is the leading cause of chronic kidney disease among recipients of renal transplants. Because modern immunosuppressive regimens have reduced the incidence of rejection-related graft loss, the probability and...
10.
Apiratpracha W, Chailimpamontree W, Intraprasong P, Yoshida E
J Med Assoc Thai
. 2008 Nov;
91(10):1623-32.
PMID: 18972909
Liver transplantation is a life saving procedure for patients with a variety of irreversible acute and chronic liver diseases for which no other therapy is available. To date, success of...